Abstract:Objective Cardiac toxicity is an important complication of chemotherapy. Selenium (Se) acts as antioxidant agent to protect myocytes from oxidative damage. Lack of Se would lead to enhancement of oxidative stress. It has been mentioned that impairment of ATP sensitive potassium channels (KATP) which are expressed in myocytes are correlated with oxidative mediated cardiac dysfunction. The possible mechanism of adriamycin (ADR) and/or Se deficiency induced cardiac dysfunction, and cardioprotective effects of Se against ADR induced cardiac toxicity were investigated in this study. Methods Animal model of cardiac dysfunction was induced by adriamycin inraperitoneal injection or/and Se deficit diet. Then by intraperitoneal injections, Se supplementation was applied to rats. We assessed cardiac function by serum brain natriuretic peptide (BNP) level, echocardiographic and hemodynamic parameters. Cardiac glutathione peroxidase (GPx) activity which mirrors oxidative stress indirectly was measured spectrophotometrically. Expression levels of KATP channels were evaluated by real-time polymerase chain reaction (PCR) and western blotting. Results The results showed that cardiac function and cardiac GPx activity decreased remarkably after administration of ADR or Se deficiency; more dramatic impairment of cardiac function and cardiac GPx activity were observed after co-administration of ADR and Se deficiency. Mechanically, down-regulation of KATP subunits gene expression in cardiac tissue was found after administration of ADR or Se deficiency; more significant inhibition of KATP subunits gene expression was identified after co-administration of ADR and Se deficiency. However, cardiac toxicity of ADR was alleviated by Se supplementation, accompanied by restoring of cardiac GPx activity and KATP subunits gene expression. Conclusions These results indicate that decreased oxidative mediated expression of KATP is involved in adriamycin and/or Se deficiency induced cardiac dysfunction; Se deficiency exacerbates adriamycin induced cardiac dysfunction by future inhibition of oxidative mediated KATP expression; Se supplementation seems to protect against adriamycin induced cardiac dysfunction by alleviating oxidative stress and then restoring KATP expression, showing potential clinical application in cancer chemotherapy.

The Cardioprotective Mechanism of Phenylaminoethyl Selenides (PAESe) Against Doxorubicin-Induced Cardiotoxicity Involves Frataxin

The antioxidant phenylaminoethyl selenide reduces doxorubicin-induced cardiotoxicity in a xenograft model of human prostate cancer

Magnesium hexacyanoferrate nanocatalysts attenuate chemodrug-induced cardiotoxicity through an anti-apoptosis mechanism driven by modulation of ferrous iron

Small-molecule mediated MuRF1 inhibition protects from doxorubicin-induced cardiac atrophy and contractile dysfunction

Selenium Attenuates Doxorubicin-Induced Cardiotoxicity Through Nrf2-NLRP3 Pathway

Pharmacological activation of GPX4 ameliorates doxorubicin-induced cardiomyopathy

Protective effect of secretory APE1/Ref‐1 on doxorubicin‐induced cardiotoxicity via suppression of ROS and p53 pathway

Paeonol protects against doxorubicin-induced cardiotoxicity by promoting Mfn2-mediated mitochondrial fusion through activating the PKCε-Stat3 pathway

Phenyl-2-aminoethyl selenide ameliorates hippocampal long-term potentiation and cognitive deficits following doxorubicin treatment

The impact of PPAR-γ/Nrf-2/HO-1, NF-κB/IL-6/ Keap-1, and Bcl-2/caspase-3/ATG-5 pathways in mitigation of DOX-induced cardiotoxicity in an animal model: The potential cardioprotective role of oxyresveratrol and/or dapagliflozin

Abstract 15199: Pyridoxamine Limits Mitochondria-Dependent Ferroptosis in a Rat Model of Doxorubicin-Induced Cardiotoxicity

Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress

ASSA13-03-37 Adriamycin Induced Cardiac Dysfunction is Attenuated by Selenium Via Restoring Oxidative Stress Mediated Expression of ATP Sensitive Potassium Channels in Rats

Hydroethanolic extract of Cirsium setidens ameliorates doxorubicin-induced cardiotoxicity by AMPK-PGC-1α-SOD-mediated mitochondrial protection

Sphingosylphosphorylcholine ameliorates doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by reducing excessive mitophagy and mitochondrial dysfunction

SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function

PAE ameliorates doxorubicin-induced cardiotoxicity via suppressing NHE1 phosphorylation and stimulating PI3K/AKT phosphorylation

Preventive Cardioprotection of Erythropoietin Against Doxorubicin-Induced Cardiomyopathy.

Exploring the role of ferroptosis in the doxorubicin-induced chronic cardiotoxicity using a murine model

Protective Effects of Psoralen Polymer Lipid Nanoparticles on Doxorubicin - Induced Myocardial Toxicity

The cardioprotective properties of Persicaria maculosa and Citrus sinensis extracts against doxorubicin-induced cardiotoxicity in mice